Adverse events and oncotargeted kinase inhibitors / Giuseppe Tridente.
Publication details: London : Academic Press, ©2017.Description: xix, 715 p. ; 28 cmISBN:- 9780128094006 (hbk.)
- 0128094001 (hbk.)
- 615.7/98 23
- RC271.P76 T75 2017

Item type | Current library | Call number | Status | Notes | Date due | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
الطب | RC 271 (Browse shelf(Opens below)) | Available | مكتبة كلية طب الموصل |
Includes bibliographical references and index.
Introduction -- Kinases -- Kinase inhibitors -- Adverse events -- Imantinib -- Gefitinib -- Erlotinib -- Sorafenib -- Sunitinib -- Dasatinib -- Lapatinib -- Nilotinib -- Pazopanib -- Vandetanib -- Vemurafenib -- Crizotinib -- Ruxolitinib -- Axitinib -- Bosutinib -- Regorafenib -- Cabozantinib -- Ponatinib -- Dabrafenib -- Trametinib -- Afatinib -- Idelaisib -- Ibrutinib -- Overview -- Conclusion and perspectives.